US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

34.62

+0.99512.96%

Volume:31.48K

Turnover:1.09M

Market Cap:111.48M

PE:- -

High:34.68

Open:33.80

Low:33.71

Close:33.62

52wk High:36.84

52wk Low:25.00

Shares:3.22M

Float Shares:3.22M

Volume Ratio:0.39

T/O Rate:0.98%

Dividend:0.39

Dividend Rate:1.13%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

CSPC Pharma's Recombinant Shingles Vaccine SYS 6052 Gains US Clinical Trial Approval

Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Envista Holdings (NVST) and Regeneron (REGN)

Hong Kong Stocks Slip as Property and Biotech ETF Sectors Rally on Policy Signals

SoftOx Names Dr. Bruce Montgomery to Chair Clinical Advisory Board

China Innovation Drug ETF (03525) Rises Over 2%, Focusing on R&D-Driven Quality Innovative Drug Companies in Hong Kong and Developed Markets

Keymed Bio-B Jumps Over 9% in Afternoon Trading, Company Holds Strong Competitive Edge Across Multiple Innovative Drug Areas Including Autoimmune and Oncology

CARSGEN-B (02171) Completes First Patient Infusion in China Phase I Registration Trial of CT1190B

Teva Wins US FDA Approval for Xgeva Biosimilar Degevma

Ocular Therapeutix Tumbles on Rival Kodiak's Trial Win, Analyst Calls Selloff Overdone

Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Kodiak Sciences (KOD)

Mirum's Liver Infection Drug Lowers Virus Levels in Late-Stage Study

Inside the Eye-Drug Breakthrough That Sent Kodiak Sciences up 156%

Amgen Stock Forecast: Sjögren’s Trial Success Tests AMGN’s Pipeline Outlook

US Drugmakers Turn to China for Licensing Deals

Mabwell's Subsidiary Lianwei Chuangyuan to Bring In Investors, Aiming to Boost Innovative Drug Business

Changchun High-Tech's GenSci136 Injection Receives Approval for Domestic Clinical Trial Application

Xilio Therapeutics Names Yariv Houvras Chief Medical Officer

Kodiak Sciences Rises After Eye-Disease Drugs Meet Trial Goals

Sun-Novo Pharmaceutical's STC008 Injection Meets Expected Goals in Phase I Trial for Cancer Cachexia in Advanced Solid Tumors

Betta Pharmaceuticals (300558.SZ): BPI-572270 Capsules Approved for Clinical Trials in Australia

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/IBBQ/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":34.62,"timestamp":1791576000000,"preClose":33.6249,"halted":0,"volume":31484,"delay":0,"changeRate":0.029594140056922128,"floatShares":3220001,"shares":3220001,"eps":0,"marketStatus":"Pre-Mkt","change":0.9951,"latestTime":"10-12 07:25:57 EDT","open":33.8,"high":34.68,"low":33.7079,"amount":1085852.840908,"amplitude":0.02891,"askPrice":40.92,"askSize":100,"bidPrice":34.3,"bidSize":300,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791811800000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":34.62,"sharesOutstanding":2520001,"nav":33.62265,"aum":111665382.5,"dividendRate":0.0113,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":34.62,"preClose":34.62,"latestTime":"19:30 EDT","volume":37,"amount":1289.62,"timestamp":1791588605827,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.39329730648058625,"impliedVol":0.14,"impliedVolPercentile":0.628},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":3220001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.39329730648058625,"shares":3220001,"dividePrice":0.3912,"high":34.68,"amplitude":0.02891,"preClose":33.6249,"low":33.7079,"week52Low":25,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":34.62,"committee":0.5,"eps":0,"divideRate":0.0113,"volume":31484,"delay":0,"ttmEps":0,"open":33.8,"prevYearClose":28.3962,"prevWeekClose":34.62,"prevMonthClose":35.14,"prevQuarterClose":35.14,"fiveDayClose":34.37,"twentyDayClose":34.472,"sixtyDayClose":32.59},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"IBBQ","amount":0.23037,"announcedDate":"2026-09-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-25"},{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1154469835","title":"CSPC Pharma's Recombinant Shingles Vaccine SYS 6052 Gains US Clinical Trial Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1154469835","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154469835?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:08","pubTimestamp":1790676512,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) has announced that its Class 1 preventive biological product, the recombinant shingles vaccine (SYS 6052), has received approval from the US Food and Drug Administration (FDA) to...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0880133367.SGD","BK1191","IE00B5MMRT66.SGD","LU0326950275.SGD","LU1226287792.SGD","LU1951186391.HKD","LU1993786604.SGD","LU0140636845.USD","LU1328277881.USD","LU1226287875.USD","PSYK","IE00BZ08YR35.GBP","LU0315179316.USD","SG9999004220.SGD","LU1960683339.HKD","MDTX","LU1807302812.USD","LU1813983027.USD","159646","IE0008368742.USD","IE00B543WZ88.USD","KURE","LU0072913022.USD","BMED","LU1226287529.USD","BK1515","IE00BZ08YS42.EUR","LU0501845795.SGD","LU1152091168.USD","LU0067412154.USD","01093","IE00BZ08YT58.USD","LU1008478684.HKD","LU0314109678.HKD","HK0000165453.HKD","LU2039709279.SGD","IBBJ","LU1226288253.USD","BK1521","IBBQ","LU1152091754.HKD","IE0008369823.USD","IE00B031HY20.USD","LU1226288170.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671290718","title":"Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Envista Holdings (NVST) and Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671290718","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671290718?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:30","pubTimestamp":1790674217,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on 4D Molecular Therapeutics (FDMT), Envista Holdings...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-4d-molecular-therapeutics-fdmt-envista-holdings-nvst-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-4d-molecular-therapeutics-fdmt-envista-holdings-nvst-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","BBH","XBI","LU0130103400.USD","LU2468319806.SGD","XLV","LU0823416689.USD","LU2362541513.USD","BK4581","FDMT","IE0034390439.USD","LU0029874061.USD","LU2089984988.USD","LU1201861165.SGD","LU0053666078.USD","BK4082","LU1917777945.USD","LU1974910355.USD","LU2237438978.USD","TBXU","LU0823434583.USD","HCSG","LU2362541273.HKD","BK4588","LU0320765992.SGD","BK4585","LU2106854487.HKD","REGN","LU0109394709.USD","IE00B19Z6F94.USD","BK4137","LU0130518102.USD","LU0058720904.USD","LU0114720955.EUR","LABU","LU0648000940.SGD","LU0289739699.SGD","IBBQ","LU0823434740.USD","LU0882574055.USD","LU0128526141.USD","BK4139","LU2023250504.SGD","LU0477156797.USD","LU2362540622.SGD","NVST","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113675289","title":"Hong Kong Stocks Slip as Property and Biotech ETF Sectors Rally on Policy Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=1113675289","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113675289?lang=en_us&edition=fundamental","pubTime":"2026-09-29 16:43","pubTimestamp":1790671392,"startTime":"0","endTime":"0","summary":"Hong Kong's three major indices closed slightly lower today, with heavyweight technology stocks weakening and structural divergence across the board standing out, while mainland property and...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","FDN","BK4585","BK4550","BK4588","BK1161","06978","LNGR","BK1574","MEDX","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671329926","title":"SoftOx Names Dr. Bruce Montgomery to Chair Clinical Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2671329926","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671329926?lang=en_us&edition=fundamental","pubTime":"2026-09-29 15:23","pubTimestamp":1790666588,"startTime":"0","endTime":"0","summary":"SoftOx names Dr. Bruce Montgomery to chair Clinical Advisory BoardSoftOx appointed Dr. A. Bruce Montgomery to establish and chair its Clinical Advisory Board ahead of a planned Phase 2b SIS study.Boar","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDLbDg5Mx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1571399168.USD","LU1934455277.USD","TMED","IE00BZ1G4Q59.USD","IE00BSNM7G36.USD","LU0234570918.USD","LU2089984988.USD","SG9999015978.USD","BK4585","LU0882574055.USD","LU1934455863.HKD","IBBQ","IE00B3T34201.USD","LU1839511570.USD","BK4568","LU0289739699.SGD","MEDI","LU0058720904.USD","LU0965509010.AUD","IE00B7SZLL34.SGD","LU0122379950.USD","BK4566","LU2112291526.USD","BK4588","BMED","IE00B19Z3B42.SGD","LU0965509101.SGD","LU1057294990.SGD","LU0320765992.SGD","LU0859254822.USD","IBB","LU0823416689.USD","LU0965509283.SGD","LU1066051498.USD","LU1674673428.USD","BK4583","LU2357627491.SGD","SG9999015986.USD","BK4578","BK4550","LU1061106388.HKD","LU1778281490.HKD","LU1066053197.SGD","LU1934455194.USD","IE0002270589.USD","TBXU","GILD","BBH","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113085280","title":"China Innovation Drug ETF (03525) Rises Over 2%, Focusing on R&D-Driven Quality Innovative Drug Companies in Hong Kong and Developed Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=1113085280","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113085280?lang=en_us&edition=fundamental","pubTime":"2026-09-29 15:22","pubTimestamp":1790666534,"startTime":"0","endTime":"0","summary":"According to Zhitong Finance APP, China Innovation Drug ETF (03525) rose over 2%, reaching 2% as of press time, at HK$10.2, with a turnover of HK$491,300.It is reported that the China Innovation Drug...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","IBBQ","WSGE","03525","FDN","BK1574","159992","BK4550","BK4585","06978","MEDX","LNGR","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110569578","title":"Keymed Bio-B Jumps Over 9% in Afternoon Trading, Company Holds Strong Competitive Edge Across Multiple Innovative Drug Areas Including Autoimmune and Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=1110569578","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110569578?lang=en_us&edition=fundamental","pubTime":"2026-09-29 13:50","pubTimestamp":1790661039,"startTime":"0","endTime":"0","summary":"Keymed Bio-B (02162) rose more than 8% in afternoon trading, climbing 8.95% as of press time to HKD 79.70, with a turnover of HKD 237 million.Earlier this month, Keymed Bio-B (02162) announced that...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","02162","BK1574","IBBQ","06978","159992","BK1583","LNGR","BK1161","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146102396","title":"CARSGEN-B (02171) Completes First Patient Infusion in China Phase I Registration Trial of CT1190B","url":"https://stock-news.laohu8.com/highlight/detail?id=1146102396","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146102396?lang=en_us&edition=fundamental","pubTime":"2026-09-29 08:10","pubTimestamp":1790640613,"startTime":"0","endTime":"0","summary":"According to an announcement by CARSGEN-B (02171), CT1190B, a universal CAR-T cell product targeting CD19/CD20, has completed the first patient infusion in its Phase I registration clinical trial...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBJ","BK1161","MDTX","BK1587","BK1585","BMED","PSYK","IBBQ","02171","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671257160","title":"Teva Wins US FDA Approval for Xgeva Biosimilar Degevma","url":"https://stock-news.laohu8.com/highlight/detail?id=2671257160","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671257160?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:00","pubTimestamp":1790625646,"startTime":"0","endTime":"0","summary":"Teva wins US FDA approval for Xgeva biosimilar DEGEVMATeva won FDA clearance for DEGEVMA (denosumab-adet), a biosimilar to Amgen’s Xgeva.Label covers Xgeva’s full uses, including prevention of bone co","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL4w4Bbr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","IE00B4R5TH58.HKD","IE00BQXX3D17.EUR","BK4139","LU0289739699.SGD","LU1057294990.SGD","LU2210149790.SGD","LU1061106388.HKD","LU2242652126.USD","BBH","IE00BQXX3F31.USD","IE00BN0W2V16.EUR","BCDF","LU0122379950.USD","BK4599","SG9999014021.USD","PBE","IBBQ","IE00BN0W2T93.GBP","LU2089984988.USD","AMGN","LU0889565916.HKD","NDAQ","SG9999014039.USD","LU1571399168.USD","BK4566","IE00BJT1NW94.SGD","BIB","IE00BN0W2W23.USD","BK4588","PJP","BK4112","IE0002141913.USD","IE00BFTCPJ56.SGD","TBXU","IE00BKPKM429.USD","BK4533","LU0320765992.SGD","LU0314104364.USD","IBB","IE0009355771.USD","LU1983299246.USD","IE00B64PRP62.GBP","SG9999014013.SGD","BK4585","LU2112291526.USD","SG9999001440.SGD","LU2468319806.SGD","LU2242646821.SGD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671252933","title":"Ocular Therapeutix Tumbles on Rival Kodiak's Trial Win, Analyst Calls Selloff Overdone","url":"https://stock-news.laohu8.com/highlight/detail?id=2671252933","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671252933?lang=en_us&edition=fundamental","pubTime":"2026-09-29 02:37","pubTimestamp":1790620623,"startTime":"0","endTime":"0","summary":"BUZZ-Ocular Therapeutix tumbles on rival Kodiak's trial win, analyst calls selloff overdone** Shares of Ocular TherapeutixOCUL.Ofall 18.8% to $7.84 in afternoon trading** Kodiak Sciences'KOD.Oexperime","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4N45K1CH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","REGN","LU2362541513.USD","BK4139","LU2023250504.SGD","TBXU","LU2362540622.SGD","LU2089984988.USD","OCUL","LU0889565916.HKD","LU0320765992.SGD","LU2362541273.HKD","LU0289739699.SGD","BK4007","LU2106854487.HKD","LU1974910355.USD","IBB","LU1917777945.USD","LU0109394709.USD","BBH","BK4505","LU2237438978.USD","LU0114720955.EUR","BK4588","LU2468319806.SGD","LU0823434740.USD","LU0882574055.USD","LU0058720904.USD","KOD","LU0823416689.USD","LU0053666078.USD","IBBQ","LU0823434583.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671259773","title":"Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Kodiak Sciences (KOD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671259773","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671259773?lang=en_us&edition=fundamental","pubTime":"2026-09-29 00:00","pubTimestamp":1790611227,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Regeneron (REGN) and Kodiak Sciences (KOD). Regeneron (REGN) Citi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regeneron-regn-and-kodiak-sciences-kod-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regeneron-regn-and-kodiak-sciences-kod-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","LU2237438978.USD","LU0823416689.USD","BK4137","LU1974910355.USD","LABU","BBH","BK4581","LU2468319806.SGD","XBI","LU2106854487.HKD","LU0128526141.USD","LU2023250504.SGD","LU0823434583.USD","XLV","LU0029874061.USD","BK4585","BK4588","HCSG","REGN","IBB","LU2362541273.HKD","LU0289739699.SGD","LU0882574055.USD","KOD","LU0823434740.USD","LU1917777945.USD","IBBQ","LU0058720904.USD","LU0320765992.SGD","TBXU","BK4139","LU0114720955.EUR","LU2362541513.USD","LU2362540622.SGD","BK4505","LU0053666078.USD","LU2089984988.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670564812","title":"Mirum's Liver Infection Drug Lowers Virus Levels in Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2670564812","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670564812?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:23","pubTimestamp":1790609027,"startTime":"0","endTime":"0","summary":"UPDATE 1-Mirum's liver infection drug lowers virus levels in late-stage studySept 28 (Reuters)-Mirum PharmaceuticalsMIRM.Oon Monday said its experimental hepatitis drug reduced levels of the virus in ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4N45K14L:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","LU0889565916.HKD","LU2357627491.SGD","LU1674673428.USD","LU1066053197.SGD","LU0861579265.USD","LU0882574055.USD","IE00B19Z3581.USD","LU0859254822.USD","LU2468319806.SGD","BK4532","LU2089984988.USD","LU1057294990.SGD","BBH","BK4139","LU1430594728.SGD","MEDI","LU1778281490.HKD","TBXU","MIRM","GILD","LU2112291526.USD","LU1934455194.USD","IE00BSNM7G36.USD","IE00B3T34201.USD","LU1585245621.USD","LU0965509283.SGD","LU0234570918.USD","LU1066051498.USD","IE0002270589.USD","BK4566","LU1839511570.USD","LU2324357040.USD","LU0965509101.SGD","LU1023059063.AUD","SG9999015986.USD","IE00BKVL7J92.USD","LU0058720904.USD","IBBQ","LU0122379950.USD","LU2087621335.USD","BMED","LU1934455863.HKD","BIB","BK4588","LU0320765992.SGD","LU0289739699.SGD","SG9999015952.SGD","TMED","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670620256","title":"Inside the Eye-Drug Breakthrough That Sent Kodiak Sciences up 156%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670620256","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670620256?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:11","pubTimestamp":1790608260,"startTime":"0","endTime":"0","summary":"Shares of Kodiak Sciences more than doubled Monday after two experimental eye drugs succeeded in a late-stage trial, positioning the biopharmaceutical company to get its first product to market.Kodiak","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237438978.USD","LU2468319806.SGD","LU2023250504.SGD","LU2106854487.HKD","IBBQ","IBB","LU0823416689.USD","BK4505","LU0823434740.USD","LU0109394709.USD","BK4139","BK4585","OTLK","KOD","LU2089984988.USD","LU0320765992.SGD","LU0053666078.USD","LU0058720904.USD","LU1917777945.USD","LU1974910355.USD","LU0114720955.EUR","LU0889565916.HKD","LU2362541513.USD","LU2362541273.HKD","LU2362540622.SGD","BK4588","LU0823434583.USD","LU0289739699.SGD","TBXU","BBH","REGN","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670256598","title":"Amgen Stock Forecast: Sjögren’s Trial Success Tests AMGN’s Pipeline Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2670256598","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670256598?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:00","pubTimestamp":1790607600,"startTime":"0","endTime":"0","summary":"TradingKey - Amgen’s latest Sjögren’s trial success adds to its pipeline, while Repatha growth and MariTide trials shape the AMGN stock outlook for 2026.","market":"other","thumbnail":"https://resource.tradingkey.com/uploads/20260928/AMGEN-b0736da492b74294b066d7d43a826369.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260928/AMGEN-b0736da492b74294b066d7d43a826369.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/262189733-stocks-amgen-stock-forecast-sjogrens-trial-maritide-2026-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0122379950.USD","LU2242652126.USD","BK4566","LU2237443622.USD","IE00BJJMRZ35.SGD","LU2237443382.USD","IE00BFTCPJ56.SGD","IE0002141913.USD","BK4533","AZN","TBXU","LU2089984988.USD","BK4581","LU0889565916.HKD","LU0320765992.SGD","LU0029864427.USD","LU0310800379.SGD","LU0128525929.USD","PJP","LU0289739699.SGD","SG9999001440.SGD","LU0432979614.USD","BK4007","LU2237443549.SGD","LU0708994859.HKD","LU2237443895.HKD","BIB","IE00B3T34201.USD","LU1571399168.USD","IBB","BK4534","LU2237443978.SGD","LU2236285917.USD","LU2237443465.HKD","IE00BJT1NW94.SGD","BBH","LU0109394709.USD","LU2112291526.USD","IE00B4R5TH58.HKD","PBE","AZNH","LU1057294990.SGD","AMGN","IE0009355771.USD","BK4588","LU2468319806.SGD","LU1829250122.USD","LU0058720904.USD","LU2456880835.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670255552","title":"US Drugmakers Turn to China for Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2670255552","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670255552?lang=en_us&edition=fundamental","pubTime":"2026-09-28 22:31","pubTimestamp":1790605880,"startTime":"0","endTime":"0","summary":"FACTBOX-US drugmakers turn to China for licensing dealsSept 28 (Reuters)-MerckMRK.Non Monday agreed to payChinese biotechSciBrunch Therapeutics $400 million upfront for global rights to an experimenta","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4N45K0UD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242652126.USD","LU0607220059.USD","IE000SO60NU8.SGD","IE00BJJMRZ35.SGD","IE00B3T34201.USD","LU1037948541.HKD","LU0133085943.USD","LU0128525929.USD","LU0965509101.SGD","LU0471298694.HKD","LU1969619763.USD","HRTS","LU0211331839.USD","LU0980610538.SGD","BK1583","IE00BFSS8Q28.SGD","LU1623119135.USD","LU2237443549.SGD","LU0353189763.USD","LU1983299246.USD","LU1267930490.SGD","LU1974910355.USD","SGXZ57979304.SGD","IE0002270589.USD","LLY","LU0321505439.SGD","IE0004445015.USD","LU2211815571.USD","LU0456855351.SGD","LU1670711040.USD","IE0004445239.USD","LU2125154778.USD","IE00BDGV0183.EUR","LU0823416689.USD","LU1093756325.SGD","LU0267386448.USD","LU1989772923.USD","LU2125154935.USD","SGXZ51526630.SGD","LU0949170772.SGD","LU1244550494.USD","IE00BLSP4452.SGD","IE00BN29S564.USD","IE000F7OJYX1.SGD","LU2491049909.HKD","LU0965509283.SGD","LU0097036916.USD","IE00BVYPNW00.USD","LU2129689514.USD","LU2087625088.SGD","KURE","LU2237443465.HKD","IE00B7KXQ091.USD","LU1868836914.USD","IE000MB6IJN5.SGD","LU1035775433.USD","LU1670710661.SGD","LU0471298777.SGD","LU2242644610.SGD","LU1934455194.USD","LU2023250330.USD","IE0002141913.USD","LU0158827781.USD","BK4599","LU2271345857.HKD","IE00BFSS7M15.SGD","BK1589","LU2087621335.USD","GB00BDT5M118.USD","LU0070302665.USD","LU2750360997.AUD","LU1923622614.USD","SG9999015341.SGD","LU1003077747.HKD","IE00BBT3K403.USD","LU0385154629.USD","LU1831875114.USD","LU0345770308.USD","TMED","LU0943347566.SGD","LU0256863902.USD","LU2168564495.EUR","LU1066053197.SGD","LU1188198961.HKD","LU2324357040.USD","LU1571399168.USD","LU2264538146.SGD","LU2471134879.HKD","LU2063271972.USD","LU1934455863.HKD","LU0061475181.USD","LU0353189680.USD","IE00BJLML261.HKD","IE0000B7K699.USD","LU0170899867.USD","LU2596442595.SGD","LU0432979614.USD","LU0868494617.USD","IE00BN8TJ469.HKD","IE0009355771.USD","LU1585245621.USD","LU2360106947.USD","LU0726765562.USD","LU2750360641.GBP","LU1670628061.USD","LU2125909247.SGD","SG9999003800.SGD","LU0985481810.HKD","LU0234572021.USD","LU1712237335.SGD","LU0354030438.USD","LU2242646821.SGD","BK4139","LU1430594728.SGD","LU0889565916.HKD","LU2362541273.HKD","LU2552382058.USD","LU1061106388.HKD","LU0310800379.SGD","SG9999015986.USD","IE00BLSP4239.USD","IE000WAW04H5.SGD","LU1064131342.USD","IE00B1XK9C88.USD","LU2028103732.USD","IBBQ","LU2111349929.HKD","LU2746668974.SGD","LU2471134952.CNY","LU2236285917.USD","LU0942090050.USD","LU1699723380.USD","FHLC","IE00B775H168.HKD","IE00BSNM7G36.USD","LU0964807845.USD","LU1201861249.SGD","LU1548497426.USD","IE00BJJMRY28.SGD","PPH","TBXU","LU0823434740.USD","LU2097828474.EUR","LU0648001328.SGD","LU0321505868.SGD","LU1496350171.SGD","LU1868837136.USD","LU0320765646.SGD","IE00BJJMRX11.SGD","LU1116320737.USD","LU1162221912.USD","LU0114720955.EUR","LU0122379950.USD","VHT","LU0208291251.USD","LU0708995401.HKD","LU1989772840.SGD","BK4532","LU2237438978.USD","LU1691799644.USD","LU0553294199.USD","LU0289961442.SGD","LU0965509010.AUD","LLYX","LU0106261372.USD","BK1161","LU0130102774.USD","LU0053666078.USD","LU2097828714.EUR","LU0225283273.USD","LU1280957306.USD","REGN","LU2756315318.SGD","LU0320765059.SGD","LU1979441026.SGD","SGXZ99366536.SGD","LU0326950275.SGD","GLAM","IE000BZT7R73.USD","LU1236620750.USD","SG9999015358.SGD","IE0001KFT4U8.USD","LU1839511570.USD","LU0289739699.SGD","LU0320765992.SGD","LU1066051225.USD","LU2456880835.USD","LU0316494557.USD","LU0072461881.USD","LU2168564065.EUR","LU0225771236.USD","LU0787776722.HKD","SG9999015978.USD","LU2129689431.USD","SG9999001176.SGD","BK4585","IE00BK4W5M84.HKD","LU0256863811.USD","LU0502904849.HKD","LU2552382215.SGD","BK4588","LU2471134796.USD","LU2360032135.SGD","IYH","SG9999014880.SGD","LU1917777945.USD","LU1023059063.AUD","LU2357627491.SGD","LU0689472784.USD","IE00B4R5TH58.HKD","LU2237443978.SGD","LU1145028129.USD","LU2097828557.USD","LU1236620834.HKD","LU0203202063.USD","ELIS","LU0098860793.USD","LU2491050154.USD","SG9999018865.SGD","LU0211328371.USD","BK4516","BK4550","LU2023251221.USD","ILDR","LU0417517546.SGD","LU0323591593.USD","LU1894683264.USD","LU1496350502.SGD","LU0683600562.USD","LU2125909593.SGD","LU2265009873.SGD","LU2746668461.USD","LU0672654240.SGD","SG9999018857.SGD","LU1629891620.HKD","IE00B19Z3581.USD","JDOC","LU2133065610.SGD","LU1232071149.USD","LU2089283258.USD","IE00B1BXHZ80.USD","LU0823434583.USD","AGNG","LU0466842654.USD","LU0225284248.USD","IE00B42XCP33.USD","LU2417539215.USD","LU0265550359.USD","LU2362540622.SGD","IE00BJT1NW94.SGD","GDOC","SG9999002224.SGD","LU0965508806.USD","LU0511384066.AUD","LU1804176565.USD","WDNA","LU0029864427.USD","LU2108987350.USD","PJP","LU0203345920.USD","BK4533","LU0861579265.USD","LU2237443895.HKD","LU0079474960.USD","SG9999015945.SGD","LU0094547139.USD","BK4007","LU1670710588.SGD","LLII","LU1267930730.SGD","LU2347655156.SGD","LU1032466523.USD","SG9999013999.USD","SG9999001440.SGD","IE00B2B36J28.USD","IE00BK4W5L77.USD","LU2602419157.SGD","LU2461242641.AUD","LU2097828805.USD","LU2361044949.HKD","IE00BFTCPJ56.SGD","LU0211327993.USD","LU1929549753.HKD","BMY","LU1267930573.SGD","LU0069063385.USD","LU2491050071.SGD","LU1720051108.HKD","LU0162691827.USD","LU2488822045.USD","THNR","LU0455707207.USD","LU0149534421.HKD","LU1670711123.USD","LU1989771016.USD","LU0234570918.USD","LU2023250843.SGD","LU0882574139.USD","LU0708994859.HKD","LU0130517989.USD","FTXH","LU0354030511.USD","LU0738911758.USD","LU1883839398.USD","IBB","LU0198837287.USD","LU1941712348.USD","LU0109394709.USD","LU1732799900.SGD","LU0310799852.SGD","LU1732800096.USD","LU2362541513.USD","SG9999014914.USD","SG9999001176.USD","LU0244354667.USD","HK0000165453.HKD","LLYZ","LU1868836591.USD","SG9999014898.SGD","SG9999017495.SGD","SG9999014567.USD","LU1074936037.SGD","LU0237698245.USD","LU0266013472.USD","LU0859254822.USD","LU1066051811.HKD","LU2106854487.HKD","BK4581","LU2462591350.SGD","IHE","LU2112291526.USD","LU1093756168.USD","IE00BKDWB100.SGD","LU0058720904.USD","BBH","LU0306807586.USD","LU1057294990.SGD","LU0820561818.USD","IE00BVYPNV92.GBP","LU2023250504.SGD","LU0868494708.USD","LU1720051017.SGD","LU2089284900.SGD","LU1551013425.SGD","LU1127390331.HKD","LU2433249047.HKD","BK4592","LU0472753341.HKD","BMED","LU2168564149.EUR","SG9999014906.USD","SG9999015952.SGD","LU2213496289.HKD","CURE","LU0306806265.USD","LU2462157665.USD","CANC","SG9999014559.SGD","LU0820562030.AUD","LU0124676726.USD","LU0265550946.USD","LU0395794307.EUR","IE00B19Z3B42.SGD","LU0320765489.SGD","LU1035773651.USD","LU0057025933.USD","PAWZ","BK4559","LU0109391861.USD","LU0661504455.SGD","LU0238689110.USD","LU0912757837.SGD","LU0158827948.USD","LU1894683348.USD","LU1988902786.USD","SG9999002232.USD","LU1366192091.USD","LU2361045086.USD","LU2237443622.USD","IE00BWXC8680.SGD","TRUH","LU1814569148.SGD","LU1934455277.USD","LU0345770993.USD","LU0096364046.USD","LU1037948897.HKD","LU0795875086.SGD","LU0640476718.USD","SG9999014542.SGD","RXL","LU1069344957.HKD","LU0174119429.USD","LU1941712264.USD","01801","MHIP","LU2756315664.SGD","LU1244550221.USD","IE00BGHQF631.EUR","BK4568","LU0463099449.HKD","LU1868836757.USD","OZEM","LU2097828631.EUR","LU2168563687.JPY","SG9999014575.USD","LU2552382132.HKD","LU1291159041.SGD","LU0210536198.USD","PFE","LU0882574055.USD","SGXZ81514606.USD","MRK","LU2089984988.USD","IXJ","LU1066051498.USD","LU2896262040.SGD","IE00BKPKM429.USD","LU1718418525.SGD","LU2129689605.HKD","LU1670627923.USD","LU0477156953.USD","LU2468319806.SGD","BK4534","LU2328871848.SGD","MEDI","LU1868837300.USD","LU0786609619.USD","IE00BFXG1179.USD","XLV","LU0689626769.HKD","LU2168564222.USD","LU2471134523.USD","MEDX","LU1261432733.SGD","LU0985320562.USD","LU2237443382.USD","BK4566","LU1551013342.USD","LU0006306889.USD","LU0545039389.USD","IE0005OL40V9.USD","SG9999011175.SGD","ELIL","LU0203201768.USD","IE000M9KFDE8.USD","LU1069347547.HKD","LU1244550577.SGD","LU0289739343.SGD","LU0795875169.SGD","SGXZ31699556.SGD","LU0820561909.HKD","ABBV","LU0203347892.USD","LU2361044865.SGD","IE00B4JS1V06.HKD","LU1323610961.USD","LU1116320901.HKD","IE00B3PB1722.GBP","LU2347655073.USD","LU2357305700.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134119945","title":"Mabwell's Subsidiary Lianwei Chuangyuan to Bring In Investors, Aiming to Boost Innovative Drug Business","url":"https://stock-news.laohu8.com/highlight/detail?id=1134119945","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134119945?lang=en_us&edition=fundamental","pubTime":"2026-09-28 22:08","pubTimestamp":1790604493,"startTime":"0","endTime":"0","summary":"Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SH) has announced that, in line with its strategic development plan and to further advance its innovative drug business while focusing on technological...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","02493","MEDX","LNGR","BK1161","BK1574","159992","688062","06978","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191494287","title":"Changchun High-Tech's GenSci136 Injection Receives Approval for Domestic Clinical Trial Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1191494287","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191494287?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:36","pubTimestamp":1790595380,"startTime":"0","endTime":"0","summary":"Changchun High-Tech Industry (Group) Co.,Ltd. (000661.SZ) has announced that its subsidiary, Changchun GeneScience Pharmaceutical Co., Ltd. (\"GeneScience Pharmaceutical\"), has received a Drug...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSYK","BK0075","MDTX","IBBJ","BK0188","BK0028","000661","BK0046","IBBQ","BK0057","BMED","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670019231","title":"Xilio Therapeutics Names Yariv Houvras Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2670019231","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670019231?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:30","pubTimestamp":1790595055,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics names Yariv Houvras chief medical officerXilio Therapeutics named Yariv J. Houvras chief medical officer on Sept. 28, 2026.He previously led clinical and translational development a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL8GCH5H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1037948897.HKD","LU1066051498.USD","BBH","IE00BN0W2V16.EUR","LU0234570918.USD","IE00BKVL7J92.USD","IE00B3QW5Z07.USD","TMED","LU0965509283.SGD","BK4566","LU1934455277.USD","LU1839511570.USD","LU0823416689.USD","SG9999014021.USD","SG9999015978.USD","LU2112291526.USD","LU1066053197.SGD","IE00BQXX3C00.GBP","LU2210150020.SGD","BCDF","IE00B3T34201.USD","IBB","IE00B19Z3B42.SGD","IE00BN0W2W23.USD","TBXU","LU2087621335.USD","IBBQ","IE00BKPKM429.USD","LU1934455863.HKD","BK4532","XLO","LU0859254822.USD","MEDI","BK4568","BMED","LU1571399168.USD","BK4583","SG9999014013.SGD","LU1430594728.SGD","LU0861579265.USD","LU2468319806.SGD","SG9999015952.SGD","LU0965509101.SGD","NDAQ","BIB","LU2089984988.USD","IE00B19Z3581.USD","GILD","LU2210149790.SGD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670239992","title":"Kodiak Sciences Rises After Eye-Disease Drugs Meet Trial Goals","url":"https://stock-news.laohu8.com/highlight/detail?id=2670239992","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670239992?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:50","pubTimestamp":1790592624,"startTime":"0","endTime":"0","summary":"BUZZ-Kodiak Sciences rises after eye-disease drugs meet trial goals** Shares of drug developer Kodiak SciencesKOD.Orise 43.9% to $46.56 premarket** Co says its experimental drugs Zenkuda and tabirafusp-ted met the main goals of a late-stage trial in patients with wet age-related macular degeneration** Both drugs achieved vision gains at one year that were not inferior to aflibercept, the comparison treatment** Wet age-related macular degeneration causes abnormal blood vessels to leak beneath the retina and can lead to loss of central vision** About 54% of Zenkuda patients reached a six-month dosing interval, potentially reducing the number of eye injections needed** Both drugs showed safety broadly consistent with aflibercept; Kodiak plans further analyses to identify which patients may benefit most from tabirafusp-ted** Co plans to seek US approval for Zenkuda in Q4 2026, using results from five successful late-stage studies across three retinal diseases** KOD up 15.7% YTD, as of last","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4N45K0P4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2106854487.HKD","IBB","LU0823416689.USD","LU0823434740.USD","BBH","LU1917777945.USD","KOD","LU2362541273.HKD","LU0114720955.EUR","LU0109394709.USD","LU2089984988.USD","LU2362540622.SGD","LU0053666078.USD","LU2468319806.SGD","LU2362541513.USD","TBXU","BK4588","LU0058720904.USD","LU0289739699.SGD","IBBQ","LU2023250504.SGD","LU0889565916.HKD","LU0320765992.SGD","REGN","BK4505","BK4585","LU2237438978.USD","LU0823434583.USD","BK4139","LU1974910355.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109891748","title":"Sun-Novo Pharmaceutical's STC008 Injection Meets Expected Goals in Phase I Trial for Cancer Cachexia in Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=1109891748","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109891748?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:08","pubTimestamp":1790590125,"startTime":"0","endTime":"0","summary":"Beijing Sun-Novo Pharmaceutical Research Co.,Ltd. (688621.SH) has announced that its wholly-owned subsidiary, Chengdu Novo-St Biotechnology Co., Ltd. (\"Novo-St\"), has achieved the expected objectives...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","PSYK","688621","IBBQ","MDTX","BK0216","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136095749","title":"Betta Pharmaceuticals (300558.SZ): BPI-572270 Capsules Approved for Clinical Trials in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=1136095749","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136095749?lang=en_us&edition=fundamental","pubTime":"2026-09-28 17:32","pubTimestamp":1790587955,"startTime":"0","endTime":"0","summary":"Betta Pharmaceuticals Co.,Ltd. (300558.SZ) has announced that its wholly-owned subsidiary, Hangzhou Jingyao Biotechnology Co., Ltd. (\"Jingyao Biotech\"), has received approval from Australia's Human...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","IBBQ","MDTX","BMED","300558","IBBJ","PSYK","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}